According to AstraZeneca's latest financial reports the company has $37.50 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $39.16 B | 5.69% |
2022-12-31 | $37.05 B | -5.67% |
2021-12-31 | $39.28 B | 151.23% |
2020-12-31 | $15.63 B | 7.14% |
2019-12-31 | $14.59 B | 3.93% |
2018-12-31 | $14.04 B | -15.61% |
2017-12-31 | $16.64 B | -0.16% |
2016-12-31 | $16.66 B | -9.94% |
2015-12-31 | $18.50 B | -5.79% |
2014-12-31 | $19.64 B | -15.51% |
2013-12-31 | $23.25 B | -2.89% |
2012-12-31 | $23.94 B | 2.05% |
2011-12-31 | $23.46 B | 0.24% |
2010-12-31 | $23.41 B | 12.43% |
2009-12-31 | $20.82 B | 29.65% |
2008-12-31 | $16.06 B | 7.68% |
2007-12-31 | $14.91 B | -3.25% |
2006-12-31 | $15.41 B | 12.6% |
2005-12-31 | $13.69 B | -5.56% |
2004-12-31 | $14.49 B | 9.35% |
2003-12-31 | $13.25 B | 18.09% |
2002-12-31 | $11.22 B | 16.59% |
2001-12-31 | $9.62 B |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $70.02 B | 86.72% | ๐บ๐ธ USA |
Novartis NVS | $39.75 B | 6.01% | ๐จ๐ญ Switzerland |
Pfizer PFE | $89.28 B | 138.09% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $38.82 B | 3.54% | ๐บ๐ธ USA |
Eli Lilly LLY | $12.89 B | -65.61% | ๐บ๐ธ USA |
Sanofi SNY | $82.20 B | 119.20% | ๐ซ๐ท France |
Biogen BIIB | $15.21 B | -59.43% | ๐บ๐ธ USA |
Merck MRK | $37.63 B | 0.36% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $16.54 B | -55.87% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $16.71 B | -55.42% | ๐ฌ๐ง UK |